Literature DB >> 8613260

Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects.

K A Jamerson1, S D Nesbitt, J V Amerena, E Grant, S Julius.   

Abstract

Insulin sensitivity may be improved with the angiotensin-converting enzyme inhibitor captopril, suggesting that inhibition of angiotensin II (Ang II) improves insulin resistance. However, the administration of systemic Ang II has also been associated with an improvement in rather than worsening of glucose utilization. Since both stimulating and antagonizing the renin-angiotensin system improve glucose uptake and both angiotensin-converting enzyme inhibitors and intravenous Ang II elicit skeletal muscle vasodilation, it is conceivable that hemodynamic factors rather than a direct effect of either Ang II or angiotensin-converting enzyme inhibitors on skeletal muscle metabolism modulate the increase in glucose utilization. The direct effects of Ang II on glucose extraction in intact human skeletal muscle have not been previously described. We investigated the effects of local infusion of Ang II on glucose uptake in the forearm of 20 healthy subjects. With the use of the isolated insulin-perfused forearm model, local plasma insulin values were raised to 100 mU/mL over fasting values and maintained there for a 90-minute infusion period. After the first 60 minutes of insulin alone, Ang II was infused into the brachial artery for the last 30 minutes. Intra-arterial Ang II infusion caused a 38% decrease in forearm blood flow (P <.05) and 59% increase in the arteriovenous glucose gradients (P <.05) to maintain a steady glucose utilization (a decrease of 4%, P=NS). Thus, local Ang II infusion does not impair insulin-stimulated glucose utilization. Furthermore, glucose extraction increases to compensate for the decrease in forearm blood flow (as the Fick principle would predict for freely diffusible substances). We conclude that the described increase in glucose utilization from systemic infusion of Ang II and during angiotensin-converting enzyme inhibitor treatment is mediated by hemodynamic factors rather than a direct effect of Ang II on skeletal muscle metabolism.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8613260     DOI: 10.1161/01.hyp.27.4.854

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  16 in total

1.  Direct Activation of Angiotensin II Type 2 Receptors Enhances Muscle Microvascular Perfusion, Oxygenation, and Insulin Delivery in Male Rats.

Authors:  Fei Yan; Zhaoshun Yuan; Nasui Wang; Robert M Carey; Kevin W Aylor; Li Chen; Xinmin Zhou; Zhenqi Liu
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

2.  Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism.

Authors:  Maggie K Diamond-Stanic; Erik J Henriksen
Journal:  Arch Physiol Biochem       Date:  2010-05       Impact factor: 4.076

3.  Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.

Authors:  H Laine; H Yki-Jarvinen; O Kirvela; T Tolvanen; M Raitakari; O Solin; M Haaparanta; J Knuuti; P Nuutila
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

4.  Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use.

Authors:  Weidong Chai; Wenhui Wang; Jia Liu; Eugene J Barrett; Robert M Carey; Wenhong Cao; Zhenqi Liu
Journal:  Hypertension       Date:  2009-12-07       Impact factor: 10.190

5.  Candesartan acutely recruits skeletal and cardiac muscle microvasculature in healthy humans.

Authors:  Matthew A Sauder; Jia Liu; Linda A Jahn; Dale E Fowler; Weidong Chai; Zhenqi Liu
Journal:  J Clin Endocrinol Metab       Date:  2012-04-16       Impact factor: 5.958

Review 6.  Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act.

Authors:  Ranganath Muniyappa; Sahzene Yavuz
Journal:  Mol Cell Endocrinol       Date:  2012-06-07       Impact factor: 4.102

Review 7.  The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome.

Authors:  Kelly Putnam; Robin Shoemaker; Frederique Yiannikouris; Lisa A Cassis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-01-06       Impact factor: 4.733

8.  Sodium nitroprusside increases human skeletal muscle blood flow, but does not change flow distribution or glucose uptake.

Authors:  O P Pitkanen; H Laine; J Kemppainen; E Eronen; A Alanen; M Raitakari; O Kirvela; U Ruotsalainen; J Knuuti; V A Koivisto; P Nuutila
Journal:  J Physiol       Date:  1999-12-15       Impact factor: 5.182

Review 9.  Prevention of type 2 diabetes mellitus through inhibition of the Renin-Angiotensin system.

Authors:  André J Scheen
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 10.  The role of the angiotensin system in cardiac glucose homeostasis: therapeutic implications.

Authors:  Elena Bernobich; Luisa de Angelis; Carlos Lerin; Giuseppe Bellini
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.